Related Experiment Videos
Malignant pathology of the breast
1Tufts University School of Medicine, Boston, Massachusetts.
Current Opinion in Obstetrics & Gynecology
|June 1, 1990
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Breast Health Center at Women & Infants Hospital: origin, philosophy, and features.
Surgical oncology clinics of North America·2000
Controversies in benign breast disease.
Surgical oncology clinics of North America·1998
Invasive breast cancer. Surgical treatment alternatives.
Obstetrics and gynecology clinics of North America·1994
Breast cancer in pregnancy.
Clinical obstetrics and gynecology·1994
Risk factors.
Obstetrics and gynecology clinics of North America·1994
Contemporary management of breast cancer.
Obstetrics and gynecology clinics of North America·1994
Shared decision-making across the urinary incontinence care continuum: implications for patient-centered care.
Current opinion in obstetrics & gynecology·2026
Advocacy around abortion in a politically charged climate.
Current opinion in obstetrics & gynecology·2026
Management of menopausal hormone therapy.
Current opinion in obstetrics & gynecology·2026
Pain control options for intrauterine device placement and endometrial biopsy.
Current opinion in obstetrics & gynecology·2026
Obstetric management and counseling for threatened periviable birth.
Current opinion in obstetrics & gynecology·2026
Sexual function after urogynecologic surgery.
Current opinion in obstetrics & gynecology·2026
Development of cecal volvulus after redo pancreas transplantation.
Journal of surgical case reports·2026
Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.
Iranian journal of otorhinolaryngology·2026
Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.
Research and practice in thrombosis and haemostasis·2026